Alcohol can affect glycemic control and interact with diabetes medications
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2)
The FDA states that the compounded drugs should only be made use of when an FDA-approved drug does not happen to meet the medical needs of a patient
At six months, people taking GLP-1 drugs were: 26 percent more likely to develop nonscarring hair loss, an umbrella term for types of hair loss where the follicles are still intact and regrowth is possible 62 percent more likely to develop pattern hair thinning, such as thinning at the crown or widening of the part in women, or a receding hairline in men
S.et al (2019b)
In both of our trials, we incorporate measures to assess not only whether GLP-1 agonists work, but also examine how they work via interrogating the hypothesized mechanisms, she told Freethink, adding that they anticipate having trial results in about 2-3 years